FDA Approves New Restless Legs Syndrome Drug Horizant
The FDA has approved a new drug called Horizant to treat moderate-to-severe restless legs syndrome.
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.
The content has been reported and it will be reviewed by a moderator.
